TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level” November 12, 2010
TCL Archive In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires June 16, 1989
TCL Archive FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs November 1, 1991
